A phase IIa study to assess the tolerability, safety, and efficacy of AZD4017 for raised intra-ocular pressure

Study identifier:D4250C00001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:2010-020932-20

CTIS identifier:N/A

Study Complete

Official Title

A Double Masked, Placebo Controlled, Randomised, Parallel Group Phase IIa Study to assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-Ocular Pressure

Medical condition

raised intraocular pressure

Phase

Phase 2

Healthy volunteers

No

Study drug

AZD4017, Placebo

Sex

All

Actual Enrollment

50

Study type

Interventional

Age

18 Years - 80 Years

Date

Study Start Date: 01 Dec 2010
Primary Completion Date: 01 Nov 2012
Study Completion Date: 01 Nov 2012

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Basic Science

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria